Mark Weinreb, CEO of BioRestorative Therapies, “Specializing in Developing Cellular Treatments for Various Diseases” at the Marcum MicroCap Conference 2012
BioRestorative Therapies, Inc. (BRTX:OTC Markets) focuses on cellular therapies for various personal medical applications. The company intends to use cell and tissue protocols, primarily involving a patients own (autologous) adult stem cells (non-embryonic), allowing patients to undergo cellular-based treatments. SNNLive spoke with Mark Weinreb, CEO of BioRestorative Therapies at the Inaugural Marcum MicroCap Conference 2012 in New York City.
“BioRestorative is a stem cell company specializing in developing cellular treatments for various diseases. We’re a non-embryonic stem cell company so therefore, we use either your own cells or we develop stem cells that can be used for the treatment of certain diseases like herniated and bulging discs, and also the treatment of obesity and diabetes type 2; are the two areas we specialize in“, Mr. Weinreb begins. “”The company is involved in developing strategies for introducing these treatments into the United States…we are very close to applying for a clinical trial for our bulging and herniated disc treatment. We already have clinical data on humans that have proven success and efficacy for the treatment of backs, so we’re very very optimistic that we’re looking for an approval process that will get us lifted for taking off the program”, he continues. For more information about BioRestorative Therapies, check out their website. SNNLive welcomes Mark Weinreb, CEO of BioRestorative Therapies.
Micro-Cap Review Latest Issue
Cavaet Emptor or Buyer Beware by SNN Inc. CEO Sheldon “Shelly” Kraft
Check out the book "Caveat Emptor" written by CEO Sheldon Kraft, click on the image to view a preview and the full book can be purchased for $15.95.
There are some best practices and good hints on what to look out for in today’s volatile markets.